Quantifying antigenic relationships among the lyssaviruses

Journal of Virology

Volumn 84, Issue 22, 2010, Pages 11841-11848

  Horton, D L ^a,b,c   McElhinney, L M ^a,g   Marston, D A ^a   Wood, J L N ^b   Russell, C A ^c,f   Lewis, N ^b,c   Kuzmin, I V ^d   Fouchier, R A M ^e   Osterhaus, A D M E ^e   Fooks, A R ^a,g   Smith, D J ^c,e,f  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b Department of Veterinary Medicine ^*  (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGENIC VARIATION; ARTICLE; GENETIC VARIABILITY; HAMSTER; HUMAN; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RABBIT; RABIES VIRUS; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; ANTIGENIC VARIATION; ANTIGENS, VIRAL; CELL LINE; CRICETINAE; HUMANS; LYSSAVIRUS; MICE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; RABBITS; RHABDOVIRIDAE INFECTIONS; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL PROTEINS;

ANIMALIA; MAMMALIA; ORYCTOLAGUS CUNICULUS; RABIES VIRUS;

EID: 78049488020     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01153-10     Document Type: Article

References (55)

1. Anonymous. 2009, posting date. Current WHO guide for rabies pre- and post-exposure prophylaxis in humans. World Health Organization, Geneva, Switzerland. http://www.who.int/rabies/PEProphylaxisguideline.pdf.
2. Arai, Y. T., I. V. Kuzmin, Y. Kameoka, and A. D. Botvinkin. 2003. New lyssavirus genotype from the lesser mouse-eared bat (Myotis blythi), Kyrghyzstan. Emerg. Infect. Dis. 9:333-337.
3. Aubert, M. 1996. Methods for the calculation of titres, p. 445-459. In F. X. Meslin, M. M. Kaplan, and H. Koprowski (ed.), Laboratory techniques in rabies. World Health Organization, Geneva, Switzerland.
4. Aubert, M. F. 1992. Practical significance of rabies antibodies in cats and dogs. Rev. Sci. Tech. 11:735-760.
5. Badrane, H., C. Bahloul, P. Perrin, and N. Tordo. 2001. Evidence of two lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J. Virol. 75:3268-3276. (Pubitemid 32225890)
6. Badrane, H., and N. Tordo. 2001. Host switching in lyssavirus history from the Chiroptera to the Carnivora orders. J. Virol. 75:8096-8104. (Pubitemid 32743682)
7. Bahloul, C., Y. Jacob, N. Tordo, and P. Perrin. 1998. DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. Vaccine 16:417-425. (Pubitemid 28010779)
8. Benmansour, A., H. Leblois, P. Coulon, C. Tuffereau, Y. Gaudin, A. Flamand, and F. Lafay. 1991. Antigenicity of rabies virus glycoprotein. J. Virol. 65:4198-4203.
9. Bourhy, H., B. Kissi, L. Audry, M. Smreczak, M. Sadkowska-Todys, K. Kulonen, N. Tordo, J. F. Zmudzinski, and E. C. Holmes. 1999. Ecology and evolution of rabies virus in Europe. J. Gen. Virol. 80:2545-2557.
10. Brookes, S. M., D. M. Healy, and A. R. Fooks. 2006. Ability of rabies vaccine strains to elicit cross-neutralising antibodies. Dev. Biol. (Basel) 125:185-193.
11. Brookes, S. M., G. Parsons, N. Johnson, L. M. McElhinney, and A. R. Fooks. 2005. Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine 23:4101-4109.
12. Calisher, C. H., J. E. Childs, H. E. Field, K. V. Holmes, and T. Schountz. 2006. Bats: important reservoir hosts of emerging viruses. Clin. Microbiol. Rev. 19:531-545.
13. Cliquet, F., M. Aubert, and L. Sagne. 1998. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J. Immunol. Methods 212:79-87. (Pubitemid 28288189)
14. Davis, P. L., E. C. Holmes, F. Larrous, W. H. Van der Poel, K. Tjornehoj, W. J. Alonso, and H. Bourhy. 2005. Phylogeography, population dynamics, and molecular evolution of European bat lyssaviruses. J. Virol. 79:10487-10497. (Pubitemid 41098588)
15. de Jong, J. C., D. J. Smith, A. S. Lapedes, I. Donatelli, L. Campitelli, G. Barigazzi, K. Van Reeth, T. C. Jones, G. F. Rimmelzwaan, A. D. Osterhaus, and R. A. Fouchier. 2007. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. J. Virol. 81:4315-4322.
16. Dietzschold, B., C. E. Rupprecht, M. Tollis, M. Lafon, J. Mattei, T. J. Wiktor, and H. Koprowski. 1988. Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies. Rev. Infect. Dis. 10(Suppl 4):S785-S798.
17. Fekadu, M., J. H. Shaddock, D. W. Sanderlin, and J. S. Smith. 1988. Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses. Vaccine 6:533-539.
18. Flamand, A., P. Coulon, F. Lafay, and C. Tuffereau. 1993. Avirulent mutants of rabies virus and their use as live vaccine. Trends Microbiol. 1:317-320. (Pubitemid 23334603)
19. Fooks, A. R., L. M. McElhinney, D. J. Pounder, C. J. Finnegan, K. Mansfield, N. Johnson, S. M. Brookes, G. Parsons, K. White, P. G. McIntyre, and D. Nathwani. 2003. Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis. J. Med. Virol. 71:281-289.
20. Garten, R. J., C. T. Davis, C. A. Russell, B. Shu, S. Lindstrom, A. Balish, W. M. Sessions, X. Xu, E. Skepner, V. Deyde, M. Okomo-Adhiambo, L. Gubareva, J. Barnes, C. B. Smith, S. L. Emery, M. J. Hillman, P. Rivailler, J. Smagala, M. de Graaf, D. F. Burke, R. A. Fouchier, C. Pappas, C. M. Alpuche-Aranda, H. Lopez-Gatell, H. Olivera, I. Lopez, C. A. Myers, D. Faix, P. J. Blair, C. Yu, K. M. Keene, P. D. Dotson, Jr., D. Boxrud, A. R. Sambol, S. H. Abid, K. St George, T. Bannerman, A. L. Moore, D. J. Stringer, P. Blevins, G. J. Demmler-Harrison, M. Ginsberg, P. Kriner, S. Waterman, S. Smole, H. F. Guevara, E. A. Belongia, P. A. Clark, S. T. Beatrice, R. Donis, J. Katz, L. Finelli, C. B. Bridges, M. Shaw, D. B. Jernigan, T. M. Uyeki, D. J. Smith, A. I. Klimov, and N. J. Cox. 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201.
21. Goudsmit, J., W. E. Marissen, W. C. Weldon, M. Niezgoda, C. A. Hanlon, A. B. Rice, J. Kruif, B. Dietzschold, A. B. Bakker, and C. E. Rupprecht. 2006. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. J. Infect. Dis. 193:796-801.
22. Hanlon, C. A., I. V. Kuzmin, J. D. Blanton, W. C. Weldon, J. S. Manangan, and C. E. Rupprecht. 2005. Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res. 111:44-54.
23. Hayman, D. T., A. R. Fooks, D. Horton, R. Suu-Ire, A. C. Breed, A. A. Cunningham, and J. L. Wood. 2008. Antibodies against Lagos bat virus in megachiroptera from West Africa. Emerg. Infect. Dis. 14:926-928.
24. Holmes, E. C., C. H. Woelk, R. Kassis, and H. Bourhy. 2002. Genetic constraints and the adaptive evolution of rabies virus in nature. Virology 292:247-257.
25. Huang, S. W., Y. W. Hsu, D. J. Smith, D. Kiang, H. P. Tsai, K. H. Lin, S. M. Wang, C. C. Liu, I. J. Su, and J. R. Wang. 2009. Reemergence of enterovirus 71 in 2008 in Taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J. Clin. Microbiol. 47:3653-3662.
26. Kissi, B., H. Badrane, L. Audry, A. Lavenu, N. Tordo, M. Brahimi, and H. Bourhy. 1999. Dynamics of rabies virus quasispecies during serial passages in heterologous hosts. J. Gen. Virol. 80:2041-2050.
27. Knobel, D. L., S. Cleaveland, P. G. Coleman, E. M. Fevre, M. I. Meltzer, M. E. Miranda, A. Shaw, J. Zinsstag, and F. X. Meslin. 2005. Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organ 83:360-368.
28. Koprowski, H. 1996. The mouse inoculation test, p. 80-86. In F. X. Meslin, M. M. Kaplan, and H. Koprowski (ed.), Laboratory techniques in rabies, 4th ed. World Health Organization, Geneva, Switzerland.
29. Kuzmin, I. V., G. J. Hughes, A. D. Botvinkin, L. A. Orciari, and C. E. Rupprecht. 2005. Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res. 111:28-43.
30. Kuzmin, I. V., M. Niezgoda, R. Franka, B. Agwanda, W. Markotter, J. C. Beagley, O. Y. Urazova, R. F. Breiman, and C. E. Rupprecht. 2008. Lagos bat virus in Kenya. J. Clin. Microbiol. 46:1451-1461.
31. Kuzmin, I. V., L. A. Orciari, Y. T. Arai, J. S. Smith, C. A. Hanlon, Y. Kameoka, and C. E. Rupprecht. 2003. Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences. Virus Res. 97:65-79.
32. Lafon, M., H. Bourhy, and P. Sureau. 1988. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice. Vaccine 6:362-368.
33. Larghi, O. P., and A. M. Diaz. 1985. Cross protection of mice against different rabies virus isolates. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 259:268-274.
34. Lentz, T. L., E. Hawrot, and P. T. Wilson. 1987. Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor. Proteins 2:298-307.
35. Leslie, M. J., S. Messenger, R. E. Rohde, J. Smith, R. Cheshier, C. Hanlon, and C. E. Rupprecht. 2006. Bat-associated rabies virus in skunks. Emerg. Infect. Dis. 12:1274-1277.
36. Lewis, P., Y. Fu, and T. L. Lentz. 2000. Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures. Muscle Nerve 23:720-730.
37. Lodmell, D. L., J. S. Smith, J. J. Esposito, and L. C. Ewalt. 1995. Cross-protection of mice against a global spectrum of rabies virus variants. J. Virol. 69:4957-4962.
38. Markotter, W., I. Kuzmin, C. E. Rupprecht, and L. H. Nel. 2008. Phylogeny of Lagos bat virus: challenges for lyssavirus taxonomy. Virus Res. 135:10-21.
39. Marston, D. A., L. M. McElhinney, N. Johnson, T. Muller, K. K. Conzelmann, N. Tordo, and A. R. Fooks. 2007. Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3′ non-translated region. J. Gen. Virol. 88:1302-1314.
40. Muller, T., B. Dietzschold, H. Ertl, A. R. Fooks, C. Freuling, C. Fehlner-Gardiner, J. Kliemt, F. X. Meslin, R. Franka, C. E. Rupprecht, N. Tordo, A. I. Wanderler, and M. P. Kieny. 2009. Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl. Trop. Dis. 3:e542.
41. Muller, T., T. Selhorst, J. Burow, A. Schameitat, and A. Vos. 2006. Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European bat lyssavirus type 1 and 2. Dev. Biol. (Basel) 125:195-204.
42. Mumford, J. A. 2007. Vaccines and viral antigenic diversity. Rev. Sci. Tech. 26:69-90.
43. Nel, L. H. 2005. Vaccines for lyssaviruses other than rabies. Expert Rev. Vaccines 4:533-540.
44. Park, A. W., J. M. Daly, N. S. Lewis, D. J. Smith, J. L. Wood, and B. T. Grenfell. 2009. Quantifying the impact of immune escape on transmission dynamics of influenza. Science 326:726-728.
45. Paweska, J. T., L. H. Blumberg, C. Liebenberg, R. H. Hewlett, A. A. Grobbelaar, P. A. Leman, J. E. Croft, L. H. Nel, L. Nutt, and R. Swanepoel. 2006. Fatal human infection with rabies-related Duvenhage virus, South Africa. Emerg. Infect. Dis. 12:1965-1967.
46. Perrin, P., Y. Jacob, A. Aguilar-Setien, E. Loza-Rubio, C. Jallet, E. Desmezieres, M. Aubert, F. Cliquet, and N. Tordo. 1999. Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine 18:479-486. (Pubitemid 29462604)
47. Prehaud, C., P. Coulon, F. LaFay, C. Thiers, and A. Flamand. 1988. Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J. Virol. 62:1-7.
48. Prosniak, M., M. Faber, C. A. Hanlon, C. E. Rupprecht, D. C. Hooper, and B. Dietzschold. 2003. Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies. J. Infect. Dis. 188:53-56.
49. Russell, C. A., T. C. Jones, I. G. Barr, N. J. Cox, R. J. Garten, V. Gregory, I. D. Gust, A. W. Hampson, A. J. Hay, A. C. Hurt, J. C. de Jong, A. Kelso, A. I. Klimov, T. Kageyama, N. Komadina, A. S. Lapedes, Y. P. Lin, A. Mosterin, M. Obuchi, T. Odagiri, A. D. Osterhaus, G. F. Rimmelzwaan, M. W. Shaw, E. Skepner, K. Stohr, M. Tashiro, R. A. Fouchier, and D. J. Smith. 2008. The global circulation of seasonal influenza A (H3N2) viruses. Science 320:340-346.
50. Schneider, L. G. 1982. Antigenic variants of rabies virus. Comp. Immunol. Microbiol. Infect. Dis. 5:101-107.
51. Seif, I., P. Coulon, P. E. Rollin, and A. Flamand. 1985. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol. 53:926-934.
52. Smith, D. J., A. S. Lapedes, J. C. de Jong, T. M. Bestebroer, G. F. Rimmelzwaan, A. D. Osterhaus, and R. A. Fouchier. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376.
53. Tuffereau, C., E. Desmezieres, J. Benejean, C. Jallet, A. Flamand, N. Tordo, and P. Perrin. 2001. Interaction of lyssaviruses with the low-affinity nerve-growth factor receptor p75NTR. J. Gen. Virol. 82:2861-2867.
54. Turmelle, A. S., L. C. Allen, F. R. Jackson, T. H. Kunz, C. E. Rupprecht, and G. F. McCracken. 2010. Ecology of rabies virus exposure in colonies of Brazilian free-tailed bats (Tadarida brasiliensis) at natural and man-made roosts in Texas. Vector Borne Zoonotic Dis. 10:165-175.
55. Wilkinson, L. 2002. History, p. 1-22. In A. C. Jackson and W. H. Wunner (ed.), Rabies. Academic Press, New York, NY.